+ 2.69
+ 1.88%

Medigus Considers Expanding Portfolio To The Field Of CBD, Medical Marijuana Outside The US

February 14, 2019 9:45 am
Share to Linkedin Share to Twitter Share to Facebook Share to Print License More

Shares of Medigus Ltd. (NASDAQ:MDGS), an Israel-based medical device company that focuses on developing minimally invasive endo-surgical tools, gained more than 11 percent early Thursday morning after saying it's eyeing the medical marijuana industry.

Medigus said in a press release it's considering expanding its portfolio to potentially include medical marijuana in markets outside of the United States. The company said it's in the "process of learning" the CBD and medical marijuana market and potential future action may include collaborations outside of the U.S.

"[T]he company's management and board of directors continue to decrease inefficiencies, expand the company's revenue streams and pursue diversification of its activity portfolio," said the press release.

Israel-based Medigus may benefit from friendly law changes as the Israeli Parliament voted in late 2018 to allow marijuana exports.

At time of publication, Medigus shares were up 3.6 percent at $3.12.

Related Links:

Israel-Based OurCrowd, 7thirty Partner To Create $30M Cannabis Tech VC Fund

Canadian Cannabis Producer To Buy Israeli Medical Cannabis Company

For the latest in financial news, exclusive stories, memes follow Benzinga on Twitter, Facebook & Instagram. For the best interviews, stock market talk & videos, subscribe to our YouTube channel.

Related Articles

Pot Stocks, ETFs, Top News And Data From The Cannabis Industry This Week